☰

Scott B. Lovitch, Ph.D. - Publications

Affiliations: 
2007 Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Griffin GK, Weirather JL, Roemer M, Lipschitz M, Kelley A, Chen PH, Gusenleitner D, Jeter E, Gjini E, Chapuy B, Rosenthal M, Xu J, Chen BJ, Sohani A, Lovitch SB, et al. Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma. Blood. PMID 32871584 DOI: 10.1182/Blood.2020006464  0.352
2019 Clement RL, Daccache J, Mohammed MT, Diallo A, Blazar BR, Kuchroo VK, Lovitch SB, Sharpe AH, Sage PT. Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses. Nature Immunology. PMID 31477921 DOI: 10.1038/S41590-019-0472-4  0.418
2018 Rodig SJ, Gusenleitner D, Jackson DG, Gjini E, Giobbie-Hurder A, Jin C, Chang H, Lovitch SB, Horak C, Weber JS, Weirather JL, Wolchok JD, Postow MA, Pavlick AC, Chesney J, et al. MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma. Science Translational Medicine. 10. PMID 30021886 DOI: 10.1126/Scitranslmed.Aar3342  0.421
2017 Rodig S, Gusenleitner D, Jackson D, Gjini E, Giobbie-Hurder A, Jin C, Chang H, Lovitch S, Horak C, Weber JS, Shipp MA, Hodi FS. Association of distinct baseline tissue biomarkers with response to nivolumab (NIVO) and ipilimumab (IPI) in melanoma: CheckMate 064. Journal of Clinical Oncology. 35: 9515-9515. DOI: 10.1200/Jco.2017.35.15_Suppl.9515  0.342
2016 Ron-Harel N, Santos D, Ghergurovich JM, Sage PT, Reddy A, Lovitch SB, Dephoure N, Satterstrom FK, Sheffer M, Spinelli JB, Gygi S, Rabinowitz JD, Sharpe AH, Haigis MC. Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. Cell Metabolism. 24: 104-17. PMID 27411012 DOI: 10.1016/J.Cmet.2016.06.007  0.34
2016 Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN, Kean LS, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. The Journal of Clinical Investigation. PMID 27294527 DOI: 10.1172/Jci85796  0.332
2015 Paterson AM, Lovitch SB, Sage PT, Juneja VR, Lee Y, Trombley JD, Arancibia-Cárcamo CV, Sobel RA, Rudensky AY, Kuchroo VK, Freeman GJ, Sharpe AH. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. The Journal of Experimental Medicine. 212: 1603-21. PMID 26371185 DOI: 10.1084/Jem.20141030  0.397
2015 Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, Burrill JS, Guo L, Sacristan C, Furlan SN, et al. Loss of Programmed Death Ligand-1 Expression on Donor T Cells Lessens Acute Graft-Versus-Host Disease Lethality Blood. 126: 147-147. DOI: 10.1182/Blood.V126.23.147.147  0.351
2014 Sage PT, Paterson AM, Lovitch SB, Sharpe AH. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity. 41: 1026-39. PMID 25526313 DOI: 10.1016/J.Immuni.2014.12.005  0.402
2007 Lovitch SB, Esparza TJ, Schweitzer G, Herzog J, Unanue ER. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. Journal of Immunology (Baltimore, Md. : 1950). 178: 122-33. PMID 17182547 DOI: 10.4049/Jimmunol.178.1.122  0.672
2006 Lovitch SB, Pu Z, Unanue ER. Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex. Journal of Immunology (Baltimore, Md. : 1950). 176: 2958-68. PMID 16493054 DOI: 10.4049/Jimmunol.176.5.2958  0.655
2006 Suri A, Lovitch SB, Unanue ER. The wide diversity and complexity of peptides bound to class II MHC molecules. Current Opinion in Immunology. 18: 70-7. PMID 16316750 DOI: 10.1016/J.Coi.2005.11.002  0.691
2005 Lovitch SB, Unanue ER. Conformational isomers of a peptide-class II major histocompatibility complex. Immunological Reviews. 207: 293-313. PMID 16181344 DOI: 10.1111/J.0105-2896.2005.00298.X  0.686
2005 Unanue E, Byersdorfer C, Carrero J, Levisetti M, Lovitch S, Pu Z, Suri A. Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common? Immunologic Research. 32: 267-92. PMID 16106079 DOI: 10.1385/Ir:32:1-3:267  0.667
2004 Pu Z, Lovitch SB, Bikoff EK, Unanue ER. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity. 20: 467-76. PMID 15084275 DOI: 10.1016/S1074-7613(04)00073-1  0.667
2003 Lovitch SB, Petzold SJ, Unanue ER. Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 171: 2183-6. PMID 12928360 DOI: 10.4049/Jimmunol.171.5.2183  0.647
2003 Lovitch SB, Walters JJ, Gross ML, Unanue ER. APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 4155-60. PMID 12682247 DOI: 10.4049/Jimmunol.170.8.4155  0.669
Show low-probability matches.